Omega-3 fatty acids do not improve endothelial function in virologically suppressed HIV-infected men: a randomized

Corrilynn O Hileman1, Teresa L Carman, Norma J Storer

  • 1Department of Medicine, Division of Infectious Diseases, MetroHealth Medical Center, Cleveland, Ohio, USA.

Insights

Omega-3 fatty acids did not improve endothelial function in adults with HIV. While inflammation markers showed a slight improvement, overall cardiovascular disease risk factors were not significantly impacted.

Area of Science:

  • Cardiology
  • Immunology
  • Virology

Background:

  • Cardiovascular disease (CVD) mortality may be reduced by omega-3 fatty acids, potentially via anti-inflammatory mechanisms.
  • Inflammation and endothelial dysfunction are implicated in the elevated CVD risk observed in individuals with HIV.
  • Stable antiretroviral therapy (ART) is crucial for managing HIV but may contribute to cardiovascular complications.

Purpose of the Study:

  • To assess the impact of omega-3 fatty acids on endothelial function and inflammation in HIV-infected adults with moderate CVD risk.
  • To determine if omega-3 supplementation can mitigate CVD risk factors in this population.

Main Methods:

  • A 24-week, randomized, double-blind, placebo-controlled trial was conducted.
  • Participants received omega-3-acid ethyl esters (1g twice daily) or a placebo.
  • Key metrics included flow-mediated dilation (FMD), lipoproteins, and biomarkers for inflammation, endothelial activation, coagulation, and insulin resistance.

Main Results:

  • No significant differences in the change of FMD were observed between the omega-3 and placebo groups.
  • Lipoprotein levels and most biomarkers did not differ between groups.
  • Soluble tumor necrosis factor receptor-I showed a trend favoring the omega-3 group, suggesting a potential anti-inflammatory effect.

Conclusions:

  • Omega-3 fatty acids did not improve endothelial function, activation, coagulation, or insulin resistance in HIV-infected men on ART.
  • A tendency towards improved inflammation markers was noted, but not sufficient to counteract HIV-related and ART-associated risks.
  • Omega-3 fatty acids may not be potent enough to overcome the pro-inflammatory and endothelial dysfunction associated with HIV and its treatment.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...